Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Sernova Corp > Uncle Phil is stepping aside!!!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by MustangSalleyon Dec 13, 2022 12:40am
156 Views
Post# 35167666

RE:RE:RE:RE:RE:Uncle Phil is stepping aside!!!

RE:RE:RE:RE:RE:Uncle Phil is stepping aside!!!

Ha good one Bioteck. Uncle Phil will go down as the captain of the Titanic. He will never sell.  Ask him how Angiotech worked out for him. He held on and missed the top and sold at the bottom.  

That what he'll do with this too.  No concept of capital markets.

Maybe we can have a fireside chat ... it is the holiday season ... we can burn marshmallows as well as the cash on hand with the burn rate. 

Ah now JPMorgan carrot is out again. Lots of deals happening there... just like Medtech deal....

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities